METTL3 in esophageal cancer: Current insights into molecular mechanisms, subtype heterogeneity and targeted therapy prospects (Review).
Saved in:
| Title: | METTL3 in esophageal cancer: Current insights into molecular mechanisms, subtype heterogeneity and targeted therapy prospects (Review). |
|---|---|
| Authors: | Pu C; Medical Research Center, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan 610031, P.R. China., Hu H; Medical Research Center, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan 610031, P.R. China., Fan H; Medical Research Center, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan 610031, P.R. China., Chen T; Department of Laboratory Medicine, Xindu District People's Hospital, Chengdu, Sichuan 610500, P.R. China., Tang J; Department of Laboratory Medicine, Xindu District People's Hospital, Chengdu, Sichuan 610500, P.R. China. |
| Source: | International journal of oncology [Int J Oncol] 2026 Jun; Vol. 68 (6). Date of Electronic Publication: 2026 Apr 24. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1791-2423 |
|---|---|
| DOI: | 10.3892/ijo.2026.5884 |
